Morgan Stanley 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-12 5:11 pm Sale | 2022-08-31 | 13G | Forte Biosciences, Inc. FBRX | MORGAN STANLEY MS | 9,084 1.100% | -35,365 (-79.56%) | Filing |
| 2022-02-11 3:02 pm Purchase | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | MORGAN STANLEY MS | 44,449 7.500% | 44,449 (New Position) | Filing |